1. 4LBA Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial. (September 2015) Authors: Choueiri, T.; Escudier, B.; Powles, T.; Mainwaring, P.; Rini, B.; Donskov, F.; Hammers, H.; Hutson, T.; Roth, B.; Peltola, K.; Lee, J.L.; Heng, D.; Schmidinger, M.; Borgman-Hagey, A.; Hessel, C.; Scheffold, C.; Schwab, G.; Tannir, N.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma. (August 2017) Authors: Penttilä, P.; Donskov, F.; Rautiola, J.; Peltola, K.; Laukka, M.; Bono, P. Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Gallbladder Cancer Treatment and Survival in Finland – A Population-based Study. (2021) Authors: Koppatz, H.; Takala, S.; Peltola, K.; But, A.; Mäkisalo, H.; Nordin, A.; Sallinen, V. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact. (2nd November 2018) Authors: Penttilä, P.; Bono, P.; Peltola, K.; Donskov, F. Journal: Acta oncologica Issue: Volume 57:Number 11(2018) Page Start: 1580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-Term Nationwide Trends in the Treatment of and Outcomes among Pancreatic Cancer Patients. (2022) Authors: Aaltonen, P.; Carpén, O.; Mustonen, H.; Puolakkainen, P.; Haglund, C.; Peltola, K.; Seppänen, H. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR). (February 2017) Authors: Schmidinger, M.; Motzer, R.J.; Powles, T.; Escudier, B.; Tannir, N.M.; Mainwaring, P.N.; Rini, B.I.; Hammers, H.J.; Donscov, F.; Roth, B.; Peltola, K.; Lee, J.L.; Heng, D.Y.C.; Aftab, D.T.; Hessel, C.; Scheffold, C.; Schwab, G.; Pal, S.; Hutson, T.E.; Choueiri, T.K. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗